Emerging bladder-sparing treatments for high risk non-muscle invasive bladder cancer
{{output}}
Bladder cancer (BC) is a significant global health concern, with non-muscle invasive bladder cancer (NMIBC) comprising 75% of cases at diagnosis. High-risk NMIBC (HR-NMIBC) poses a significant therapeutic challenge due to its high recurrence and progression ra... ...
